Voltar
Revisão Acesso aberto Revisado por pares
BIBTEX RIS

Dual-subtype FIV vaccine (Fel-O-Vax® FIV) protection against a heterologous subtype B FIV isolate

2005; SAGE Publishing; Volume: 7; Issue: 1 Linguagem: Inglês

10.1016/j.jfms.2004.08.005

ISSN

1532-2750

Autores

Ruiyu Pu, James Coleman, James G. Coisman, Eiji Sato, Taishi Tanabe, Maki Arai, Janet K. Yamamoto,

Tópico(s)

Virus-based gene therapy research

Resumo

Vaccine trials were undertaken to determine whether the Fel-O-Vax FIV, a commercial dual-subtype (subtypes A and D) feline immunodeficiency virus (FIV) vaccine, is effective against a subtype B FIV isolate. Current results demonstrate the Fel-O-Vax FIV to be effective against a subtype B virus, a subtype reported to be the most common in the USA.

Referência(s)